L-xylulose Chemical Properties

Melting point:

Not Applicable

Boiling point:

469.1±45.0 °C(Predicted)

Density 

1.516±0.06 g/cm3(Predicted)

Flash point:

>230 °F

storage temp. 

2-8°C

solubility 

Methanol (Slightly), Water (Soluble)

form 

syrup

pka

11.90±0.20(Predicted)

color 

light yellow

optical activity

+33

LogP

-1.200 (est)

Safety Information

WGK Germany 

3

HS Code 

29400090

MSDS

• Language:English Provider:SigmaAldrich

L-xylulose Usage And Synthesis

Chemical Properties

L-xylulose is a clear liquid. It is a ketopentose, meaning that it has five carbon atoms and a ketogroup at carbon C-2. It has a molecular formula of C5H10O5 and a molar mass of 150.13 g/mol. Xylulose is almost colorless and it forms syrup. The formation of crystals has not been reported (Budavari, 1996). Both D- and L - enantiomers of xylulose are found as intermediates in metabolic pathways of prokaryotes as well as eukaryotes. Both forms are rare in nature (Doten and Mortlock, 1985b).

Uses

L-Xylulose is used in studies relating to potential inhibitors of glycosidases and has been proven to inhibit oligosaccharide processing to a degree.

Definition

ChEBI: L-xylulose is a xylulose. It has a role as a human metabolite, an Escherichia coli metabolite and a mouse metabolite. It is an enantiomer of a D-xylulose.

Application

L-Xylulose has been shown to be a specific inhibitor of certain α-glucosidases,while having virtually no effect on other glycosidases such as β-glucosidase or α- and β-mannosidases. Furthermore,it is a specific inhibitor of the N-linked glycoproteinprocessing enzyme，glucosidase I, but does not inhibit glucosidase I or otherglycoprotein processing mannosidases. Thus it could prove to be a useful inhibitor forstudying glycoprotein processing, especially as it has been proven to be non-toxic andto also be effective in cell cultures (Muniruzzaman et al., 1996). L-Xylulose has been shown to have a strong inhibitory effect on the a-glucosidases，sucrase and maltase, present in the small intestine. Thus, an L-xylulose containing drug preparation for reducing blood sugar levels in humans and animals has been patented (Heinz et al.,1998).

Preparation

In 1933 a synthetic procedure for producing small amounts of D- and L -xylulose was introduced. In this method D- or L-xylose is epimerized to the corresponding diastereomer. The isomerization of xylose in pyridine leads to the production of xylulose (Touster, 1962). This enzyme catalyzes the production of L-xylulose from xylitol using either PQQ (pyrroloquinoline quinone) or FAD (flavin adenine dinucleotide) as prosthetic group, and L-xylulose is accumulated in the medium (Adachi et al., 1999; Adachi et al., 2001).

L-xylulose(527-50-4)Related Product Information

• 9H-Xanthen-9-one, 2-[(2E)-3,7-dimethyl-2,6-octadien-1-yl]-1,3,6,7-tetrahydroxy-
• 2-Deoxy-D-xylose
• Xanthone Impurity 9
• 4-[(1R)-1,5-Dimethyl-4-hexen-1-yl]-6-hydroxy-2-cycloehexen-1-one
• Benzene, 4-[(1S)-1,5-dimethyl-4-hexen-1-yl]-2-methoxy-1-methyl-
• 7-ACETYLLYCOPSAMINE
• XANTHORRHIZOL
• 5H-Furo[3,2-b]xanthene-2-carboxylic acid, 2,3-dihydro-11-methyl-5-oxo-
• 5-[(1R)-1,5-Dimethyl-4-hexen-1-yl]-2-methyl-3-cyclohexene-1,1-diol
• 4-[(1R)-1,5-Dimethyl-4-hexen-1-yl]-2-cyclohexen-1-one
• [5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-[hydroxy-(3,4,5-trihydroxyoxan-2-yl)oxy-phosphoryl]oxy-phosphinic acid
• 3-Morpholinopropanol
• D-[2-2H]XYLOSE
• Xanthone Impurity 11
• Xanthophyll
• 1H-Benzimidazole, 1-(1-oxo-2-propenyl)-2-(4-thiazolyl)-
• D-Xylose, 5-deoxy-
• D-(+)-MELEZITOSE